WallStreetZenWallStreetZen

NASDAQ: IMDX
Insight Molecular Diagnostics Inc Stock Ownership - Who owns Insight Molecular Diagnostics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Insight Molecular Diagnostics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrea S. JamesChief Financial Officer2025-02-0797,561$2.05
$200.00kBuy
Patrick W. Smith10% Owner2025-02-07385,814$2.05
$790.92kBuy
Patrick W. Smith10% Owner2025-02-071,077,600$2.05
$2.21MBuy
Broadwood Partners LP10% Owner2025-02-06660,207$2.05
$1.35MBuy
Broadwood Partners LP10% Owner2025-02-064,505,488$2.05
$9.24MBuy
Patrick W. Smith10% Owner2025-02-0425$2.02
$50.50Buy
Patrick W. Smith10% Owner2025-01-31890$2.01
$1.79kBuy
Patrick W. Smith10% Owner2025-01-30318$2.01
$639.18Buy
Patrick W. Smith10% Owner2025-01-293,880$2.01
$7.80kBuy
Patrick W. Smith10% Owner2025-01-14100$2.08
$208.00Buy

1 of 2

IMDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMDX insiders and whales buy or sell their stock.

IMDX Shareholders

What type of owners hold Insight Molecular Diagnostics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pura Vida Investments LLC122.11%34,922,779$89.75MInsider
Broadwood Partners LP91.35%26,126,461$67.15MInsider
Broadwood Capital Inc39.90%11,410,100$29.32MInstitution
Lineage Cell Therapeutics Inc21.12%6,041,154$15.53MInsider
John Peter Gutfreund17.13%4,900,047$12.59MInsider
George Karfunkel12.80%3,659,860$9.41MInsider
Patrick W. Smith11.39%3,258,485$8.37MInsider
Awm Investment Company Inc9.87%2,822,530$7.25MInstitution
Pura Vida Investments LLC3.31%947,134$2.43MInstitution
Alfred D. Kingsley2.10%601,990$1.55MInsider

1 of 3

IMDX vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMDX16.42%83.58%Net Buying
BNR2.04%0.00%
VNRX20.39%36.92%Net BuyingNet Buying
NOTV23.56%39.39%Net BuyingNet Selling
BDSX36.42%55.80%Net BuyingNet Buying
View Top Diagnostic & Research Stocks

Insight Molecular Diagnostics Stock Ownership FAQ

Who owns Insight Molecular Diagnostics?

Insight Molecular Diagnostics (NASDAQ: IMDX) is owned by 56.27% institutional shareholders, 286.41% Insight Molecular Diagnostics insiders, and 0.00% retail investors. Pura Vida Investments LLC is the largest individual Insight Molecular Diagnostics shareholder, owning 34.92M shares representing 122.11% of the company. Pura Vida Investments LLC's Insight Molecular Diagnostics shares are currently valued at $89.75M.

If you're new to stock investing, here's how to buy Insight Molecular Diagnostics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.